Nexera director Carmel Liron reports share holdings

Nexera Technologies Ltd director Carmel Liron reported beneficial ownership of 1,255 ordinary shares.

Rhea-AI Filing Summary

Nexera Technologies Ltd director Carmel Liron reported beneficial ownership of 1,255 ordinary shares. This includes 242 restricted share units (RSUs) granted on September 16, 2025 and 1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% over time.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Carmel Liron

Role Director

Type	Security	Shares	Price	Value
holding	Ordinary shares	--	--	--

Holdings After Transaction: Ordinary shares — 1,255 shares (Direct)

Footnotes (1)

1. F1. Represents (i) 242 restricted share units ("RSUs") Granted on September 16, 2025 and the vesting commencement date is September 10, 2025, which vest in equal quarterly installments of 12.5% beginning on December 10, 2025, of which 60 have vested and 182 remain unvested as of March 18, 2026; and (ii) 1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% beginning on January 1, 2026, all of which remain unvested as of March 18, 2026.

Key Figures

Ordinary shares owned: 1,255 shares September 16, 2025 RSU grant: 242 RSUs Vested RSUs from 2025 grant: 60 RSUs +3 more

6 metrics

Ordinary shares owned 1,255 shares Total beneficial ownership following reporting entry

September 16, 2025 RSU grant 242 RSUs Granted September 16, 2025, vesting 12.5% quarterly from December 10, 2025

Vested RSUs from 2025 grant 60 RSUs Portion of 242 RSUs vested as of March 18, 2026

Unvested RSUs from 2025 grant 182 RSUs Remain unvested as of March 18, 2026

January 1, 2026 RSU grant 1,013 RSUs Granted January 1, 2026, vesting 12.5% quarterly from that date

Unvested RSUs from 2026 grant 1,013 RSUs All remain unvested as of March 18, 2026

Key Terms

restricted share units ("RSUs"), vesting commencement date, equal quarterly installments of 12.5%, unvested

4 terms

restricted share units ("RSUs") financial

"Represents (i) 242 restricted share units ("RSUs") Granted on September 16, 2025..."

vesting commencement date financial

"vesting commencement date is September 10, 2025, which vest in equal quarterly installments..."

The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.

equal quarterly installments of 12.5% financial

"which vest in equal quarterly installments of 12.5% beginning on December 10, 2025..."

unvested financial

"of which 60 have vested and 182 remain unvested as of March 18, 2026..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Carmel Liron report in this Nexera Technologies (NEXR) Form 3/A?

Carmel Liron reported beneficial ownership of 1,255 ordinary shares of Nexera Technologies Ltd. This total reflects time-based restricted share units (RSUs) granted in 2025 and 2026, which vest quarterly, rather than a recent market purchase or sale.

How many RSUs from the September 16, 2025 grant does Carmel Liron hold at Nexera (NEXR)?

Carmel Liron received 242 RSUs on September 16, 2025, vesting 12.5% quarterly from December 10, 2025. As of March 18, 2026, 60 RSUs have vested and 182 RSUs remain unvested, reflecting ongoing equity-based compensation.

What are the details of Carmel Liron’s January 1, 2026 RSU grant at Nexera Technologies?

On January 1, 2026, Carmel Liron was granted 1,013 RSUs, vesting in equal quarterly installments of 12.5% beginning the same day. As of March 18, 2026, all 1,013 RSUs remain unvested, indicating these awards are still entirely subject to future vesting.

Does this Nexera (NEXR) Form 3/A show insider buying or selling by Carmel Liron?

The Form 3/A reflects holdings and RSU grants, not explicit open-market buying or selling. Transaction fields show an unknown transaction code and classify this as a holding entry, so it mainly updates the reported equity position.

How do the RSU vesting schedules work for Carmel Liron at Nexera Technologies?

Both RSU grants vest in equal quarterly installments of 12.5%. The September 2025 grant starts vesting December 10, 2025, while the January 2026 grant begins vesting January 1, 2026. Over time, more RSUs convert into ordinary shares as they vest.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/07/2026 - 04:05 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Carmel Liron

(Last) (First) (Middle)

7 MEZADA STREET

(Street)

BNEI BRAK 5126112

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Nexera Technologies Ltd [ NEXR ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)
03/18/2026

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	1,255(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents (i) 242 restricted share units ("RSUs") Granted on September 16, 2025 and the vesting commencement date is September 10, 2025, which vest in equal quarterly installments of 12.5% beginning on December 10, 2025, of which 60 have vested and 182 remain unvested as of March 18, 2026; and (ii) 1,013 RSUs granted on January 1, 2026, which vest in equal quarterly installments of 12.5% beginning on January 1, 2026, all of which remain unvested as of March 18, 2026.

	/s/ Liron Carmel	05/07/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)